The recent convertible bond issue by Telix Pharmaceuticals shines a light on the ongoing reopening of equity capital markets (ECM), driven by positive fundamentals on the equity side along with improved sentiments for growth-related investments. This deal highlights how companies are capitalising on favourable market conditions, raising funds while keeping risk in check. As made… Continue reading What the Telix Convertible Bond Says About the Market Environment
